NASDAQ
Total Transactions
13
5 buys /8 sells
Shares Acquired
111,004
Transactions: 5•Avg: 22,200.8
Shares Disposed
149,882
Transactions: 8•Avg: 18,735.25
Net Activity
-38,878
Net Selling•Ratio: 62.5%
Q4 2025(Current) | 111,004 | 149,882 | -38,878 | 62.50% |
Q3 2025 | 48,000 | 103,717 | -55,717 | 30.00% |
Q2 2025 | 38,694 | 16,596 | +22,098 | 120.00% |
Q1 2025 | 266,209 | 2,530,761 | -2,264,552 | 77.78% |
Q4 2024 | 390,104 | 44,328 | +345,776 | 100.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 38,878 shares•Acquired/Disposed Ratio: 62.5%
Net Activity | |||||
|---|---|---|---|---|---|
APOCAPMC ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 10 percent owner | 2 | 0 | 999,896 | -999,896 |
LTS Lam Thomas S. | Director | 11 | 123,780 | 803,591 | -679,811 |
SKT Sim Kenneth T. | Director, officer: executive chairman | 8 | 283,780 | 757,444 | -473,664 |
SB Sim Brandon | Officer: ceo and president | 4 | 180,028 | 108,421 | +71,607 |
KDM Kumar Dinesh M. | Officer: chief medical officer | 10 | 93,939 | 27,846 | +66,093 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-08 | Director | Purchase | 29,502 | $17.78 | $524,545.56 | 459,122 | |
2025-12-08 | Director | Sale | 25,866 | $22 | $569,052 | 433,256 | |
2025-12-08 | Director | Sale | 29,502 | $17.78 | $524,545.56 | - | |
2025-11-10 | Director, officer: executive chairman | Purchase | 29,502 | $17.78 | $524,545.56 | 639,407 | |
2025-11-10 | Director, officer: executive chairman | Sale | 29,502 | $17.78 | $524,545.56 | - |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
LTS Lam Thomas S. | Director | Dec 10, 2025 | |
LTS Lam Thomas S. | Director | Dec 10, 2025 | |
LTS Lam Thomas S. | Director | Dec 10, 2025 | |
SKT Sim Kenneth T. | Director, officer: executive chairman | Nov 13, 2025 | |
SKT Sim Kenneth T. | Director, officer: executive chairman | Nov 13, 2025 |
Net change in shares shown on right
No price data available for this timeframe.